Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01698
|
|||||
| Drug Name |
Glutathione-S-S-glutathione
|
|||||
| Synonyms |
oxiglutatione; glutathione disulfide; GSSG; oxidized glutathione; Glutathione disulphide; L-Glutathione oxidized; Glutathione-ssg; Glutathione, oxidized; Oxigluthione; glutathione oxidized; Glutathone disulfide; Bi(glutathion-S-yl); Oxidized L-glutathione; L-Oxidized glutathione; L(-)-Glutathione; Oxiglutatione [INN]; S,S'-Ethylenebis(glutathione); Oxiglutationum [INN-Latin]; Oxiglutationa [INN-Spanish]; CCRIS 780; OXIDIZED GLUTATHIONE DISULFIDE; Glutathiol; UNII-ULW86O013H
|
|||||
| Indication | Ovarian cancer [ICD11: 2C73] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C20H32N6O12S2
|
|||||
| Canonical SMILES |
C(CC(=O)NC(CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)C(=O)NCC(=O)O)C(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/t9-,10-,11-,12-/m0/s1
|
|||||
| InChIKey |
YPZRWBKMTBYPTK-BJDJZHNGSA-N
|
|||||
| CAS Number |
CAS 27025-41-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 612.6 | Topological Polar Surface Area | 368 | ||
| Heavy Atom Count | 40 | Rotatable Bond Count | 21 | |||
| Hydrogen Bond Donor Count | 10 | Hydrogen Bond Acceptor Count | 16 | |||
| XLogP |
-9.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:17858
|
|||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [3] | ||
| MRP3 | Transporter Info | Multidrug resistance-associated protein 3 | Substrate | [4] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00345540) Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer | |||||
| 2 | Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta. 1997 May 22;1326(1):12-22. | |||||
| 3 | Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. Eur J Biochem. 1999 Oct 1;265(1):281-9. | |||||
| 4 | MRP2 and 3 in health and disease. Cancer Lett. 2006 Mar 8;234(1):51-61. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.